Rocket Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US77313F1066

SecurityRCKT / Rocket Pharmaceuticals, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in RCKT / Rocket Pharmaceuticals, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Rocket Pharmaceuticals, Inc. (US:RCKT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 42,495 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (RCKT) in the form of stock options. The firm currently holds call options representing 118,500 of underlying shares valued at $424,230 USD and put options representing 7,000 of underlying shares valued at $25,060 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RCKT / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -42,495 -100.00 0 -100.00
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 42,495 42,495 149 0.0001
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -41,379 -100.00 0 0.0000
2025-08-05 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 41,379 41,379 0 0.0001
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -6,096 -100.00 0 0.0000
2025-02-11 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 6,096 5,633 1,216.63 0 0.0000
2024-11-08 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 463 -5,362 -92.05 0 0.0000
2024-07-25 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 5,825 5,825 0 0.0001
2024-02-02 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -101,928 -100.00 0 -100.00
2023-11-01 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 101,928 101,928 2 0.0016
2023-08-04 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -3,385 -100.00 0 0.0000
2023-04-27 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 3,385 3,385 0 0.0001
2022-11-04 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -452 -100.00 0 -100.00
2022-08-03 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 452 452 6 0.0000
2021-08-12 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -1,350 -100.00 0 -100.00
2021-04-26 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,350 1,030 321.88 59 247.06 0.0001
2021-02-02 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 320 -10,701 -97.10 17 -93.23 0.0000
2020-10-14 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 11,021 2,036 22.66 251 33.51 0.0003
2020-07-13 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 8,985 -309 -3.32 188 45.74 0.0003
2020-04-29 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 9,294 9,294 3.44 129 -31.38 0.0002
2019-10-15 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -507 -100.00 0 -100.00
2019-07-26 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 507 507 7 0.0000
2019-01-16 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -4,497 -100.00 0 -100.00
2018-10-23 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 4,497 2,399 114.35 110 168.29 0.0004
2018-07-30 2018-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 2,098 2,098 -53.35 41 -62.73 0.0002
2018-01-10 2017-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 0 -5,440 -100.00 0 -100.00
2017-10-25 2017-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 5,440 898 19.77 9 12.50 0.0004
2017-07-12 2017-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 4,542 -3,021 -39.94 8 -46.67 0.0003
2017-04-21 2017-03-31 13F INOTEK PHARMACEUTICALS COM 45780V102 7,563 -32,800 -81.26 15 -93.90 0.0006
2017-01-11 2016-12-31 13F INOTEK PHARMACEUTICALS COM 45780V102 40,363 34,661 607.87 246 355.56 0.0147
2016-10-07 2016-09-30 13F INOTEK PHARMACEUTICALS COM 45780V102 5,702 -24,761 -81.28 54 -76.11 0.0037
2016-07-18 2016-06-30 13F INOTEK PHARMACEUTICALS COM 45780V102 30,463 30,463 226 0.0151
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ROCKET PHARMACEUTICALS CALL Call 118,500 112.37 424 117.44 n/a n/a n/a
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS CALL Call 55,800 -77.11 196 n/a n/a n/a
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS CALL Call 243,800 69.31 1 n/a n/a n/a
2025-08-05 2025-06-30 13F ROCKET PHARMACEUTICALS CALL Call 144,000 68.62 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS CALL Call 85,400 1,642.86 1 n/a n/a n/a
2025-02-11 2024-12-31 13F ROCKET PHARMACEUTICALS CALL Call 4,900 -27.94 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ROCKET PHARMACEUTICALS CALL Call 6,800 518.18 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ROCKET PHARMACEUTICALS CALL Call 1,100 -95.47 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ROCKET PHARMACEUTICALS CALL Call 24,300 -50.10 1 -100.00 n/a n/a n/a
2024-02-02 2023-12-31 13F ROCKET PHARMACEUTICALS CALL Call 48,700 70.28 1 n/a n/a n/a
2023-11-01 2023-09-30 13F ROCKET PHARMACEUTICALS CALL Call 28,600 -1.38 1 n/a n/a n/a
2023-08-04 2023-06-30 13F ROCKET PHARMACEUTICALS CALL Call 29,000 339.39 1 n/a n/a n/a
2023-04-27 2023-03-31 13F ROCKET PHARMACEUTICALS CALL Call 6,600 -90.77 0 -100.00 n/a n/a n/a
2023-02-02 2022-12-31 13F ROCKET PHARMACEUTICALS CALL Call 71,500 87.66 1 -99.84 n/a n/a n/a
2022-11-04 2022-09-30 13F ROCKET PHARMACEUTICALS CALL Call 38,100 486.15 608 583.15 n/a n/a n/a
2022-08-03 2022-06-30 13F ROCKET PHARMACEUTICALS CALL Call 6,500 75.68 89 53.45 n/a n/a n/a
2022-05-02 2022-03-31 13F ROCKET PHARMACEUTICALS CALL Call 3,700 12.12 58 -19.44 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ROCKET PHARMACEUTICALS CALL Call 3,300 -89.32 72 -94.96 n/a n/a n/a
2022-02-04 2021-12-31 13F ROCKET PHARMACEUTICALS CALL Call 30,900 1,428 n/a n/a n/a
2021-10-28 2021-09-30 13F ROCKET PHARMACEUTICALS CALL Call 30,900 0.32 1,428 4.69 n/a n/a n/a
2021-08-12 2021-06-30 13F ROCKET PHARMACEUTICALS CALL Call 30,800 18,343.11 1,364 84.32 n/a n/a n/a
2021-04-26 2021-03-31 13F ROCKET PHARMACEUTICALS CALL Call 167 438.71 740 335.29 n/a n/a n/a
2021-02-02 2020-12-31 13F ROCKET PHARMACEUTICALS CALL Call 31 -81.44 170 -77.03 n/a n/a n/a
2020-10-14 2020-09-30 13F ROCKET PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-13 2020-06-30 13F ROCKET PHARMACEUTICALS CALL Call 6 -76.00 12 -64.71 n/a n/a n/a
2020-04-29 2020-03-31 13F ROCKET PHARMACEUTICALS CALL Call 25 4.17 34 -37.04 n/a n/a n/a
2020-02-05 2019-12-31 13F ROCKET PHARMACEUTICALS CALL Call 24 118.18 54 350.00 n/a n/a n/a
2019-10-15 2019-09-30 13F ROCKET PHARMACEUTICALS CALL Call 11 1,000.00 12 1,100.00 n/a n/a n/a
2019-07-26 2019-06-30 13F ROCKET PHARMACEUTICALS CALL Call 1 -95.00 1 -97.14 n/a n/a n/a
2019-04-18 2019-03-31 13F ROCKET PHARMACEUTICALS CALL Call 20 1,900.00 35 3,400.00 n/a n/a n/a
2018-07-30 2018-06-30 13F ROCKET PHARMACEUTICALS CALL Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-04-26 2018-03-31 13F ROCKET PHARMACEUTICALS CALL Call 64 -1.54 16 300.00 n/a n/a n/a
2018-01-10 2017-12-31 13F INOTEK PHARMACEUTICALS CALL Call 65 -5.80 4 33.33 n/a n/a n/a
2017-10-25 2017-09-30 13F INOTEK PHARMACEUTICALS CALL Call 69 -68.64 3 0.00 n/a n/a n/a
2017-07-12 2017-06-30 13F INOTEK PHARMACEUTICALS CALL Call 220 94.69 3 200.00 n/a n/a n/a
2017-04-21 2017-03-31 13F INOTEK PHARMACEUTICALS CALL Call 113 135.42 1 -91.67 n/a n/a n/a
2017-01-11 2016-12-31 13F INOTEK PHARMACEUTICALS CALL Call 48 -4.00 12 500.00 n/a n/a n/a
2016-10-07 2016-09-30 13F INOTEK PHARMACEUTICALS CALL Call 50 316.67 2 100.00 n/a n/a n/a
2016-07-18 2016-06-30 13F INOTEK PHARMACEUTICALS CALL Call 12 0.00 1 -50.00 n/a n/a n/a
2016-04-14 2016-03-31 13F INOTEK PHARMACEUTICALS CALL Call 12 -77.78 0 -100.00 n/a n/a n/a
2016-01-20 2015-12-31 13F INOTEK PHARMACEUTICALS CALL Call 54 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ROCKET PHARMACEUTICALS PUT Put 7,000 -41.18 25 -39.02 n/a n/a n/a
2026-02-11 2025-12-31 13F ROCKET PHARMACEUTICALS PUT Put 11,900 -40.80 42 n/a n/a n/a
2025-11-12 2025-09-30 13F ROCKET PHARMACEUTICALS PUT Put 20,100 3.61 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ROCKET PHARMACEUTICALS PUT Put 19,400 26.80 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS PUT Put 15,300 -1.92 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ROCKET PHARMACEUTICALS PUT Put 15,600 457.14 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ROCKET PHARMACEUTICALS PUT Put 2,800 -20.00 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ROCKET PHARMACEUTICALS PUT Put 3,500 -55.70 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ROCKET PHARMACEUTICALS PUT Put 7,900 -46.62 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ROCKET PHARMACEUTICALS PUT Put 14,800 -69.61 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ROCKET PHARMACEUTICALS PUT Put 48,700 2,463.16 1 n/a n/a n/a
2023-08-04 2023-06-30 13F ROCKET PHARMACEUTICALS PUT Put 1,900 -75.64 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ROCKET PHARMACEUTICALS PUT Put 7,800 290.00 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ROCKET PHARMACEUTICALS PUT Put 2,000 400.00 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ROCKET PHARMACEUTICALS PUT Put 400 -91.84 6 -91.04 n/a n/a n/a
2022-08-03 2022-06-30 13F ROCKET PHARMACEUTICALS PUT Put 4,900 345.45 67 294.12 n/a n/a n/a
2022-05-02 2022-03-31 13F ROCKET PHARMACEUTICALS PUT Put 1,100 17 n/a n/a n/a
2021-08-12 2021-06-30 13F ROCKET PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-04-26 2021-03-31 13F ROCKET PHARMACEUTICALS PUT Put 38 -39.68 168 -51.30 n/a n/a n/a
2021-02-02 2020-12-31 13F ROCKET PHARMACEUTICALS PUT Put 63 65.79 345 105.36 n/a n/a n/a
2020-07-13 2020-06-30 13F ROCKET PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-04-29 2020-03-31 13F ROCKET PHARMACEUTICALS PUT Put 37 825.00 51 466.67 n/a n/a n/a
2020-02-05 2019-12-31 13F ROCKET PHARMACEUTICALS PUT Put 4 9 n/a n/a n/a
2018-01-10 2017-12-31 13F INOTEK PHARMACEUTICALS PUT Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-10-25 2017-09-30 13F INOTEK PHARMACEUTICALS PUT Put 80 53.85 6 -88.89 n/a n/a n/a
2017-07-12 2017-06-30 13F INOTEK PHARMACEUTICALS PUT Put 52 8.33 54 980.00 n/a n/a n/a
2017-04-21 2017-03-31 13F INOTEK PHARMACEUTICALS PUT Put 48 -94.48 5 -95.73 n/a n/a n/a
2017-01-11 2016-12-31 13F INOTEK PHARMACEUTICALS PUT Put 869 43,350.00 117 11,600.00 n/a n/a n/a
2016-10-07 2016-09-30 13F INOTEK PHARMACEUTICALS PUT Put 2 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.